Ceretha Thomas
Psychiatric/Mental Health · McDonough, GANPI 1124061791
Payments from drug & device makers
Across 172 payments — averaging $19.12 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$529
- Lundbeck LLC$431
- Otsuka America Pharmaceutical, Inc.$407
- Teva Pharmaceuticals USA, Inc.$349
- Neurocrine Biosciences, Inc.$282
- AbbVie$273
- plus $1K from 7 others
What the payments were for
- Food & beverage$3,22998%
- Education$602%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 26 | $529 |
| Lundbeck LLC | 24 | $431 |
| Otsuka America Pharmaceutical, Inc. | 24 | $407 |
| Teva Pharmaceuticals USA, Inc. | 11 | $349 |
| Neurocrine Biosciences, Inc. | 14 | $282 |
| AbbVie | 19 | $273 |
| Vanda Pharmaceuticals Inc. | 9 | $263 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 14 | $241 |
| Alkermes, Inc. | 12 | $211 |
| Indivior Inc. | 14 | $200 |
| Sunovion Pharmaceuticals Inc. | 3 | $59 |
| Braeburn Inc. | 1 | $27 |
| Eisai Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- AUSTEDO$106
How this compares
$3,289 in reported general payments places this provider in the 90th percentile of 900 psychiatric/mental health providers in Georgia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Invega SustennaPaliperidone Palmitate | 17 | $53,422 |
| Aripiprazole | 20 | $2,524 |
| Prazosin Hcl | 16 | $497 |
| Duloxetine Hcl | 27 | $369 |
| Bupropion Hcl SrBupropion Hcl | 15 | $243 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Johnson & JohnsonInvega Sustenna | $529 | $53,42217 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 900 psychiatric/mental health providers in Georgia.
Other psychiatric/mental health in McDonough
- Phyillis Kennedy-HowellBarney$673K
- Jessica OliverThomasville$233K
- Sherri KrollBrunswick$155K
- Taylor LeblancAlbany$48K
- Greta HeckmannDalton$28K
- Matthew DowdyWoodstock$25K
- Natasha GilesLoganville$21K
- Darrick SealeyWarner Robins$17K
- Olufunke AdewunmiSmyrna$13K
- Bradley MosherSuwanee$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.